StromaForte / Cellcolabs - LARVOL DELTA

A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration (clinicaltrials.gov) - P1/2 | N=30 | Recruiting | Sponsor: Cellcolabs Clinical LTD. | N=12 ➔ 30 | Trial completion date: Sep 2024 ➔ Oct 2028 | Trial primary completion date: May 2024 ➔ Oct 2027

Enrollment change • Stroma • Trial completion date • Trial primary completion date • Musculoskeletal Diseases

A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events (clinicaltrials.gov) - P1/2 | N=100 | Recruiting | Sponsor: Cellcolabs Clinical LTD. | N=30 ➔ 100 | Trial completion date: Jul 2024 ➔ Oct 2029 | Trial primary completion date: Apr 2024 ➔ Oct 2029

Enrollment change • Stroma • Trial completion date • Trial primary completion date • Cardiovascular • IL6 • TNFA

A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty (clinicaltrials.gov) - P1/2 | N=12 | Not yet recruiting | Sponsor: Cellcolabs Clinical LTD. | Trial completion date: Jan 2025 ➔ Jan 2027 | Initiation date: Oct 2023 ➔ Jan 2025 | Trial primary completion date: Oct 2024 ➔ Jan 2026

Stroma • Trial completion date • Trial initiation date • Trial primary completion date • TNFA

A Study to Evaluate Allogenic Bone-Marrow Mesenchymal Stromal Cell Product StromaForte in Aging Frailty Patients (clinicaltrials.gov) - P1/2 | N=12 | Recruiting | Sponsor: Cellcolabs Clinical SPV Limited | Trial completion date: Apr 2024 ➔ Apr 2025

Trial completion date • TNFA

A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events (clinicaltrials.gov) - P1/2 | N=30 | Recruiting | Sponsor: Cellcolabs Clinical LTD.

New P1/2 trial • Stroma • Cardiovascular

A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis (clinicaltrials.gov) - P1/2 | N=12 | Recruiting | Sponsor: Cellcolabs Clinical SPV Limited

New P1/2 trial • Stroma • Immunology • Osteoarthritis • Pain • Rheumatology • IL6 • TNFA